Tiragolumab in combination with atezolizumab and bevacizumab in patients with unresectable, locally advanced or metastatic hepatocellular carcinoma (MORPHEUS-Liver): a randomised, open-label, phase 1b–2, study
Richard Finn,Baek‐Yeol Ryoo,Chiun Hsu,Daneng Li,Adam M. Burgoyne,Christopher Cotter,Shreya Badhrinarayanan,Yulei Wang,Anqi Yin,Tirupathi Rao Edubilli,Sami Mahrus,Matthew H. Secrest,Colby S. Shemesh,Nancy Xiaonan Yu,Stephen P. Hack,Edward Cha,Edward Gane